home / stock / jazz / jazz news


JAZZ News and Press, Jazz Pharmaceuticals plc From 09/09/20

Stock Information

Company Name: Jazz Pharmaceuticals plc
Stock Symbol: JAZZ
Market: NASDAQ
Website: jazzpharmaceuticals.com

Menu

JAZZ JAZZ Quote JAZZ Short JAZZ News JAZZ Articles JAZZ Message Board
Get JAZZ Alerts

News, Short Squeeze, Breakout and More Instantly...

JAZZ - Jazz Pharmaceuticals Announces New Research Collaboration with Redx Pharma to Discover and Develop Two Targeted Cancer Therapies

Research Collaboration on Two Targeted Oncology Programs in the Ras/Raf/MAP Kinase Pathway Redx to Receive $10 Million Upfront and $10 Million in Year 2 with up to $400 Million in Further Milestone Payments Plus Tiered Royalties on any Future Net Product Sales DUBLIN , Sept....

JAZZ - Jazz Pharmaceuticals Announces Participation at Three Upcoming Virtual Investor Conferences

DUBLIN , Sept. 8, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the company will webcast its corporate presentations at the following virtual investor conferences: Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2020 at ...

JAZZ - Etsy, Teradyne and Catalent Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600

NEW YORK , Sept. 4, 2020 /PRNewswire/ -- S&P Dow Jones Indices will make the following index adjustments to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 to ensure each index more appropriately represents its market capitalization range. The changes will be effective pr...

JAZZ - Tesla -4.3% as S&P 500 rebalance skips automaker

In a fairly heavy shuffle, several companies are moving among the S&P 500 Index, the S&P MidCap 400 and SmallCap 600 as part of September's quarterly rebalance. More news on: Tesla, Inc., Etsy, Inc., Teradyne, Inc., Stocks on the move, Read more ...

JAZZ - Why This Top Venture Capitalist Is Raising Money With a Biotech SPAC

A special purpose acquisition company (SPAC) is a publicly traded shell company that raises capital with the intent of acquiring a private business. SPACs have become an intriguing alternative for companies that want to go public because they allow that to happen much faster than with an init...

JAZZ - Jazz Pharmaceuticals to Present New Data on Xywav(TM) (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Sunosi® (solriamfetol) at Virtual SLEEP 2020

10 new abstracts to showcase Jazz leadership and new data in sleep medicine research and therapies DUBLIN , Aug. 27, 2020 /PRNewswire/ --   Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that 10 abstracts will be presented at Virtual SLEEP 2020, the 34 th annual meeting...

JAZZ - ImmunoGen: Turning Around In A Coronavirus Environment

The stock market is filled with individuals who know the price of everything, but the value of nothing. - Phillip Fisher In the cancer research world, the space of antibody-drug conjugates has performed an interesting resurrection in recent years. Yes, they’ve been approved sinc...

JAZZ - Tudor buys TMUS, adds Citi, cuts SPY

Tudor Investment reports fund value of $2.02B as on June 30th, 2020. More news on: Advanced Disposal Services, Inc., T-Mobile US, Inc., Netflix, Inc., Consumer stocks news, Tech stocks news, Financial stocks news, News on ETFs Read more ...

JAZZ - IPO Update: Harmony Biosciences Seeks $100 Million IPO

Quick Take Harmony Biosciences Holdings ( HRMY ) intends to raise $100 million from the sale of its common stock in an IPO, according to an amended registration statement. The company is advancing development and commercialization of narcolepsy and related treatments. HRMY has shown a st...

JAZZ - Jazz Pharma adds to Q2 beat/guidance raise-stoked rally

Jazz Pharmaceuticals ( JAZZ +3.3% ) is up again, albeit on below-average volume, adding to its up move after its posted better-than-expected Q2 results with more bullish guidance Tuesday after the close. Shares have rallied  14%  since then. Highlights: More news on: Jazz Pharm...

Previous 10 Next 10